Both in Pharmaceuticals
Regeneron Pharmaceuticals vs Abbott Laboratories
Over the past year REGN returned +44.5% and ABT returned −14.2%; their daily moves had a correlation of 0.20.
REGN +44.5% ABT −14.2%Growth of $1, one year, split-adjusted
| Metric | REGN | ABT |
|---|---|---|
| Price | $927.89 | $106.20 |
| Market cap | $95.99B | $183.77B |
| Today | +13.33% | +1.56% |
| 1 month | +26.3% | +9.8% |
| 6 months | +32.3% | +18.7% |
| Year to date | +20.2% | −15.2% |
| 1 year | +42.1% | −14.7% |
| Revenue growth (YoY) | +36.3% | +13.0% |
| Gross margin | 88.8% | 57.7% |
| Net margin | 38.1% | 7.4% |
| P/E (TTM) | 19.9× | 33.9× |
| Price / sales | 5.7× | 3.9× |
| Net cash | $6.59B | -$27.00B |
| Dividend yield | 0.41% | 2.37% |
| Volatility (60d) | 37.0% | 21.3% |
| Short % of float | 2.2% | 1.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).